Close

UPDATE: Statera Biopharma (STAB) Receives Nasdaq Delisting Decision, Scheduled Hearing for October 6

Go back to UPDATE: Statera Biopharma (STAB) Receives Nasdaq Delisting Decision, Scheduled Hearing for October 6

Form 8-K Statera Biopharma, Inc. For: Sep 22

September 27, 2022 11:27 AM EDT

false 0001318641 0001318641 2022-09-22 2022-09-22   UNITED... More